North America
In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diver...
February 18, 2023 | News
The capital expansion plan includes a new state-of-the-art, fully automated cGMP sterile filling line with the flexibility to fill vials, syringes, a...
February 17, 2023 | News
Biotage has entered into an agreement to acquire Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a global li...
February 15, 2023 | News
The collaboration will continue to leverage Sentia’s proprietary peptide-based platform and Neurocrine’s drug development expertise in CR...
February 15, 2023 | News
AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China announced ...
February 14, 2023 | News
Modified agreement also includes the development of an updated vaccine in fall 2023 Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to...
February 14, 2023 | News
MedHQ, a leading provider of technology-enabled expert services including human resources, staffing, and financial management to outpatient healthcar...
February 10, 2023 | News
As part of NWSS, Biobot contributes data from more than 400 locations from over 250 counties across a total of 50 states and U.S. Territories, providing co...
February 09, 2023 | News
Parse Biosciences, a leading provider of accessible and scalable single-cell sequencing solutions, today announced the availability of Evercode&trade...
February 08, 2023 | News
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...
February 03, 2023 | News
As part of this review process, Magenta will explore potential strategic alternatives that may include, but are not limited to, an acquisition, merger, bus...
February 03, 2023 | News
Both companies join forces to identify and alleviate indoor mycotoxins and molds that can contribute to symptoms associated with sick building syndrome. Si...
February 02, 2023 | News
Amgen (NASDAQ:AMGN) announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the Un...
February 01, 2023 | News
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr....
January 30, 2023 | News
Most Read
Bio Jobs
News